TITLE

Systemic AAV6 Delivery Mediating RNA Interference Against SOD1: Neuromuscular Transduction Does Not Alter Disease Progression in fALS Mice

AUTHOR(S)
Towne, Chris; Raoul, Cédric; Schneider, Bernard L.; A.ebischer, Patrick
PUB. DATE
June 2008
SOURCE
Molecular Therapy;Jun2008, Vol. 16 Issue 6, p1018
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder arising from the selective death of motor neurons. Approximately 20% of familial ALS (fALS) cases are caused by toxic gain-of-function mutations in the superoxide dismutase 1 (SOD1) gene. We as well as others have provided proof-of-principle for the use of RNA interference (RNAi) against mutant SOD1 as a potential therapy for fALS. With the aim of maximizing the delivery of these silencing instructions, we explored the efficacy of intravenous delivery of recombinant adeno-associated virus (rAAV) serotype 6 expressing small hairpin RNAs targeting mutant SOD1 in the G93A SOD1 fALS mouse model. This approach resulted in a systemic transduction profile, corresponding to transduction of the entire skeletal musculature as well as heart and liver. In addition, motor neurons at all levels of the spinal cord and brain stem were transduced, amounting to 3–5% of the lower motor neuron pool. SOD1 protein levels were reduced by >50% in all the muscles that were examined. Crucially, this silencing profile did not alter the course of the disease in this fALS model, thereby providing compelling evidence that SOD1-mediated damage within skeletal muscles does not contribute to death of motor neurons in ALS. Further, this study demonstrates that motor neurons can be transduced across the length of the spinal cord through a single noninvasive delivery of rAAV.Molecular Therapy (2008) 16 6, 1018–1025 doi:10.1038/mt.2008.73
ACCESSION #
35349589

 

Related Articles

  • Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity. Dodge, James C.; Haidet, Amanda M.; Yang, Wendy; Passini, Marco A.; Hester, Mark; Clarke, Jennifer; Roskelley, Eric M.; Treleaven, Christopher M.; Rizo, Liza; Martin, Heather; Kim, Soo H.; Kaspar, Rita; Taksir, Tatyana V.; Griffiths, Denise A.; Cheng, Seng H.; Shihabuddin, Lamya S.; Kaspar, Brian K. // Molecular Therapy;Jun2008, Vol. 16 Issue 6, p1056 

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of the motor system. Recent work in rodent models of ALS has shown that insulin-like growth factor-1 (IGF-1) slows disease progression when delivered at disease onset. However, IGF-1's mechanism of action along the...

  • FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD. Orozco, Denise; Edbauer, Dieter // Journal of Molecular Medicine;Dec2013, Vol. 91 Issue 12, p1343 

    Mutations in fused in sarcoma (FUS) in a subset of patients with amyotrophic lateral sclerosis (ALS) linked this DNA/RNA-binding protein to neurodegeneration. Most of the mutations disrupt the nuclear localization signal which strongly suggests a loss-of-function pathomechanism, supported by...

  • Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice. Ganay, Thibault; Boizot, Alexia; Burrer, Renaud; Chauvin, Jean Paul; Bomont, Pascale // Molecular Neurodegeneration;2011, Vol. 6 Issue 1, p25 

    Background: Giant Axonal Neuropathy (GAN) is a fatal neurodegenerative disorder with early onset characterized by a severe deterioration of the peripheral and central nervous system, involving both the motor and the sensory tracts and leading to ataxia, speech defect and intellectual...

  • FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/ FTLD. Yusuke Fujioka; Shinsuke Ishigaki; Akio Masuda; Yohei Iguchi; Tsuyoshi Udagawa; Hirohisa Watanabe; Masahisa Katsuno; Kinji Ohno; Gen Sobue // Scientific Reports;8/9/2013, p1 

    FUS is genetically and pathologically linked to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). To clarify the RNA metabolism cascade regulated by FUS in ALS/FTLD, we compared the FUS-regulated transcriptome profiles in different lineages of primary cells from...

  • Impairment of mitochondrial DNA repair enzymes against accumulation of 8-oxo-guanine in the spinal motor neurons of amyotrophic lateral sclerosis. Kikuchi, Hitoshi; Furuta, Akiko; Nishioka, Ken-ichi; Suzuki, Satoshi O.; Nakabeppu, Yusaku; Iwaki, Toru // Acta Neuropathologica;Apr2002, Vol. 103 Issue 4, p408 

    Oxidative stress plays an important role in the pathogenesis of amyotrophic lateral sclerosis (ALS). In the present study, we investigated the expression of two major human enzymes that prevent errors caused by 8-oxoguanine (8-oxoG), a mitochondrial form of 8-oxoG DNA glycosylase (hOGG1) and...

  • Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord. Braak, Heiko; Ludolph, Albert; Thal, Dietmar R.; Del Tredici, Kelly // Acta Neuropathologica;Jul2010, Vol. 120 Issue 1, p67 

    Skein-like and spherical inclusions within the somatodendritic compartment of a few types of susceptible neurons in the human nervous system are the currently acknowledged pathological hallmarks of amyotrophic lateral sclerosis (ALS). These inclusions consist chiefly of an aggregated,...

  • VEGF: multitasking in ALS. Velde, Christine Vande; Cleveland, Don W // Nature Neuroscience;Jan2005, Vol. 8 Issue 1, p5 

    Amyotrophic lateral sclerosis is an incurable paralyzing disorder caused by the death of motor neurons in the spinal cord and brainstem. Patients typically die within three to five years. In this issue, Storkebaum and colleagues offer new evidence for VEGF action in motor neuron survival and new...

  • Neurophysiological features of fasciculation potentials evoked by transcranial magnetic stimulation in amyotrophic lateral sclerosis. de Carvalho, M.; Miranda, P. C.; de Lourdes Sales Luís, M.; Ducla-Soares, E. // Journal of Neurology;Mar2000, Vol. 247 Issue 3, p189 

    We report 13 patients with amyotrophic lateral sclerosis in whom fasciculation potentials (FPs) driven by transcranial magnetic stimulation (TMS) were recorded. A total of 18 different FPs were analyzed. TMS-driven fasciculations had a simple morphology and were stable. Complex potentials were...

  • Autoradiography with [3H]PK11195 of spinal tract degeneration in amyotrophic lateral sclerosis. Sitte, H. H.; Wanschitz, J.; Budka, H.; Berger, M. L. // Acta Neuropathologica;Feb2001, Vol. 101 Issue 2, p75 

    The diagnostic hallmarks of amyotrophic lateral sclerosis (ALS) are degeneration of upper and lower motor neurons and of corticospinal tracts. Here, we demonstrate the suitability of the gliosis marker [3H]PK11195 for quantitative evaluation of tract degeneration in ALS in vitro. Binding of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics